SynopsisTyphoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. The global Typhoid Vi Po.....
SynopsisDTaP (diphtheria, tetanus, and acellular pertussis) vaccine, which is given to children. DT (diphtheria and tetanus) vaccine, which is given to children. Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine, which is given to adolescents and adu.....
SynopsisPolio vaccines are vaccines used to prevent poliomyelitis (polio). The global Poliovirus Vaccine market size is expected to reach US$ 955.4 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant appli.....
SynopsisInactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin. The global Poliovirus Vaccine Inactivated market size is expected to reach US$ 926.8 million by 2029, gr.....
SynopsisInactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin. The global Inactivated Poliovirus Vaccine market size is expected to reach US$ 926.8 million by 2029, gr.....
SynopsisPneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F. The global 10-Valent Pneumococcal Polysaccharide Vaccine market size is expec.....
SynopsisMenomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Th.....
SynopsisMeningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. The global Meningococcal Group B Vaccine market size is expected to reach US$ 2034.2 million by 2029, growing at a CAGR of 8.6% from 2023 to 2029. The market is.....
SynopsisThe MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The global Measles, Mumps, and Rubella Virus Vaccine market size is expected to reach US$ 506.6 million by 2029, growing at a CAGR of 3.8% from 2023 to 2029. The market is.....
SynopsisJapanese Encephalitis vaccine info for parents, public, and healthcare professionals. The global Japanese Encephalitis Virus Vaccine market size is expected to reach US$ 572.2 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is ma.....
